Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids.
about
The role of ANGPTL3 in controlling lipoprotein metabolismAtherogenic dyslipidemia in children: evaluation of clinical, biochemical and genetic aspectsAngiopoietin-Like Proteins: A Comprehensive LookAssociation between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol-diabetes connection? A systematic review of literature.Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes.Metabolism of plasma cholesterol and lipoprotein parameters are related to a higher degree of insulin sensitivity in high HDL-C healthy normal weight subjects.Hepatic ANGPTL3 regulates adipose tissue energy homeostasis.Silencing of ANGPTL 3 (angiopoietin-like protein 3) in human hepatocytes results in decreased expression of gluconeogenic genes and reduced triacylglycerol-rich VLDL secretion upon insulin stimulation.Hypobetalipoproteinemia and abetalipoproteinemia.Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion.ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys.Circulating angiopoietin-like protein 8 (ANGPTL8) and ANGPTL3 concentrations in relation to anthropometric and metabolic profiles in Korean children: a prospective cohort studyEffects of Regular Recreational Exercise Training on Serum ANGPTL3-Like Protein and Lipid Profile in Young Healthy Adults.Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism.Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis.Changes in triglycerides and high-density lipoprotein cholesterol may precede peripheral insulin resistance, with 2-h insulin partially mediating this unidirectional relationship: a prospective cohort study.Update on primary hypobetalipoproteinemia.ANGPTL3 Deficiency and Protection Against Coronary Artery Disease.ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients.Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes.ANGPLT3: A novel modulator of lipid metabolism.ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase.Tissue expression and predicted protein structures of the bovine ANGPTL3 and association of novel SNPs with growth and meat quality traits.Angiopoietin-like 3 in lipoprotein metabolism.ANGPTL3 serum concentration and rare genetic variants in Finnish population.New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.Analysis of circulating angiopoietin-like protein 3 and genetic variants in lipid metabolism and liver health: the DiOGenes study.RNA Therapeutics in Cardiovascular Precision Medicine
P2860
Q26769679-9D3E2266-8D71-4BCB-A7A2-5D4FF026C13CQ28546605-6B2A0EE6-C8FE-458A-A6EA-6444E537007AQ29395294-E2A5DFED-A9D7-43D3-A3A4-FCB89D7DA543Q30241977-5E5BFC9D-B959-4B6E-A2EA-518183D74B65Q33887783-EE9917C8-DD06-4518-A221-3346E1CD025CQ34462764-C96D989D-67D4-40F0-852E-FBDB3D42B45BQ34490931-647C8A47-1804-4FA9-89F2-0107A63522FCQ34706796-AD065022-D070-4AF6-8DCF-4F8796ACB8C3Q35738368-373C5903-4378-4699-82D4-1A57A27DAFE0Q35776630-014D3013-5528-4FBD-9569-0A9E3AD58C6DQ35776636-57F3AB6D-85D3-4891-B29B-487F6D60AB07Q36433236-69D4AF90-794F-4FA5-88B3-E8E5D58851B5Q36490921-D4DD55CC-12B4-4556-B529-79735904B41EQ36930209-4AF7DA1C-27D5-4D29-96C2-86021C5F4407Q37251396-4C7BC800-C555-44E1-98B4-E67363A81114Q37305417-29246FA9-9C96-4E24-85AD-C2F7811C4ED8Q37394438-3B00612D-193A-48E2-93A5-253E2D926995Q38208223-15CDADE8-0D81-46DB-81EB-954EC4CAE683Q40254292-CC215AF5-8770-416C-A218-47F71E35708FQ40635839-B3D07FCA-425D-4DB4-9D75-1851718134CBQ40965986-FC425FA8-DFB5-4231-B199-85E55A450A78Q42367565-5DDDB6DE-69ED-4FB2-8A07-257FDB349AE1Q42377853-AE8CB1CA-19B2-4758-9264-58D36E09AFBCQ46731705-575E8FC4-A0D5-4FAE-BE9C-AC85F5A64D08Q47688043-AA94DF9D-ECF6-4F4B-993F-46947DFDC7DFQ47708524-C73C25D1-EDF2-42F5-B472-A28F736616B4Q50044216-85EB4A69-66D5-4B5E-91A7-9A2722EA3C51Q55128897-74D56160-7E87-4ABC-8FE7-26AD7187EFD9Q57174720-0BD82C51-9ABE-4A74-ADDE-F037B17CCDB1
P2860
Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Angptl3 deficiency is associat ...... reased serum free fatty acids.
@en
Angptl3 deficiency is associat ...... reased serum free fatty acids.
@nl
type
label
Angptl3 deficiency is associat ...... reased serum free fatty acids.
@en
Angptl3 deficiency is associat ...... reased serum free fatty acids.
@nl
prefLabel
Angptl3 deficiency is associat ...... reased serum free fatty acids.
@en
Angptl3 deficiency is associat ...... reased serum free fatty acids.
@nl
P2093
P50
P1476
Angptl3 deficiency is associat ...... reased serum free fatty acids.
@en
P2093
Andre Bensadoun
Anna Lahikainen
Anna Montali
Christian Ehnholm
Daniel Rader
Ester Ciociola
Fabrizio Ceci
Jari Metso
Marcello Arca
Marianna Maranghi
P304
P356
10.1161/ATVBAHA.113.301397
P407
P577
2013-05-09T00:00:00Z